Search

everythinglearnresearchcommunity

for

Search:↓

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

The document concludes that clinicians should be aware of common hair and scalp disorders in women of African descent and that more research is needed to develop effective treatments.

Quick treatment of hair disorders in teenage girls is important because of the emotional effects.

Proper education can prevent traction alopecia in women of color.

A 66-year-old man with a rare case of male frontal fibrosing alopecia did not regrow hair despite treatment.

COVID-19 may harm male fertility and damage the reproductive system.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

The pandemic changed how often certain skin conditions were diagnosed.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

People with Lichen Planopilaris tend to be more depressed, have lower self-esteem, and a worse quality of life.

Low-level laser therapy may reduce symptoms and increase hair thickness in lichen planopilaris patients.

Managing frontal fibrosing alopecia and lichen planus pigmentosus is challenging due to resistant hair loss and skin discoloration.

Lichen Planopilaris in teens is rare, often misdiagnosed, and responds well to steroids.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

A woman with severe angioedema improved significantly after treatment with rituximab.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Oral minoxidil can increase or maintain hair thickness in most people with lichen planopilaris, with mild side effects.

Early treatment helps stop hair loss in women of color.

Seven patients were misdiagnosed with discoid lupus instead of lichen planopilaris due to similar symptoms, showing the need for careful diagnosis in scarring hair loss conditions.

Two plywood factory workers developed contact dermatitis from phenol-formaldehyde resin, a known allergen.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.

In Singapore, most skin reactions to drugs were in females and Chinese, often caused by painkillers, antibiotics, and some other drugs, with serious cases linked to genetics.

Platelet-rich plasma is tolerable for lichen planopilaris and doesn't worsen the condition, but its effectiveness is unclear.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.